Details for New Drug Application (NDA): 064030
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 064030
Tradename: | ERYTHROMYCIN |
Applicant: | Sentiss |
Ingredient: | erythromycin |
Patents: | 0 |
Pharmacology for NDA: 064030
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 064030
Suppliers and Packaging for NDA: 064030
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN | erythromycin | OINTMENT;OPHTHALMIC | 064030 | ANDA | ST. MARY'S MEDICAL PARK PHARMACY | 60760-670 | 60760-670-35 | 1 TUBE in 1 CARTON (60760-670-35) / 3.5 g in 1 TUBE |
ERYTHROMYCIN | erythromycin | OINTMENT;OPHTHALMIC | 064030 | ANDA | Proficient Rx LP | 63187-267 | 63187-267-35 | 1 TUBE in 1 CARTON (63187-267-35) / 3.5 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;OPHTHALMIC | Strength | 0.5% | ||||
Approval Date: | Jul 18, 1996 | TE: | AT | RLD: | No |
Complete Access Available with Subscription